Table of Contents 2018-2025 Squamous Non-Small Cell Lung Cancer Therapeutics Report on Global and United States Market, Status and Forecast, by Players, Types and Applications 1 Methodology and Data Source 1.1 Methodology/Research Approach 1.1.1 Research Programs/Design 1.1.2 Market Size Estimation 1.1.3 Market Breakdown and Data Triangulation 1.2 Data Source 1.2.1 Secondary Sources 1.2.2 Primary Sources 1.3 Disclaimer 2 Squamous Non-Small Cell Lung Cancer Therapeutics Market Overview 2.1 Squamous Non-Small Cell Lung Cancer Therapeutics Product Overview 2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Market Segment by Type 2.2.1 BMS-906024 2.2.2 Buparlisib Hydrochloride 2.2.3 FP-1039 2.2.4 Ipilimumab 2.2.5 JNJ-42756493 2.2.6 Lenvatinib 2.2.7 Others 2.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Product Segment by Type 2.3.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025) 2.3.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Market Share (%) by Type (2013-2018) 2.3.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Market Share (%) by Type (2013-2018) 2.3.4 Global Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Pcs) by Type (2013-2018) 2.4 United States Squamous Non-Small Cell Lung Cancer Therapeutics Product Segment by Type 2.4.1 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth by Type (2013, 2017 and 2025) 2.4.2 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Market Share by Type (2013-2018) 2.4.3 United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018) 2.4.4 United States Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Pcs) by Type (2013-2018) 3 Squamous Non-Small Cell Lung Cancer Therapeutics Application/End Users 3.1 Squamous Non-Small Cell Lung Cancer Therapeutics Segment by Application/End Users 3.1.1 Research Center 3.1.2 Hospital 3.1.3 Clinic 3.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Product Segment by Application 3.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025) 3.2.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Market Share (%) by Application (2013-2018) 3.3 United States Squamous Non-Small Cell Lung Cancer Therapeutics Product Segment by Application 3.3.1 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025) 3.3.2 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Market Share (%) by Application (2013-2018) 4 Squamous Non-Small Cell Lung Cancer Therapeutics Market Status and Outlook by Regions 4.1 Global Market Status and Outlook by Regions 4.1.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and CAGR by Regions (2013, 2017 and 2025) 4.1.2 North America 4.1.3 Asia-Pacific 4.1.4 Europe 4.1.5 South America 4.1.6 Middle East and Africa 4.1.7 United States 4.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Revenue by Regions 4.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Market Share (%) by Regions (2013-2018) 4.2.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Market Share (%) by Regions (2013-2018) 4.2.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 4.2.4 North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 4.2.5 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 4.2.6 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 4.2.7 South America Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) 4.2.8 Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 4.2.9 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) 5 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Competition by Players/Manufacturers 5.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Market Share by Players (2013-2018) 5.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Share by Players (2013-2018) 5.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Average Price (USD/Pcs) by Players (2013-2018) 5.4 Global Top Players Squamous Non-Small Cell Lung Cancer Therapeutics Manufacturing Base Distribution, Sales Area, Product Types 5.5 Squamous Non-Small Cell Lung Cancer Therapeutics Market Competitive Situation and Trends 5.5.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Concentration Rate 5.5.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share (%) of Top 3 and Top 5 Players 5.5.3 Mergers & Acquisitions, Expansion 6 United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Competition by Players/Manufacturers 6.1 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Market Share by Players (2013-2018) 6.2 United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Share by Players (2013-2018) 6.3 United States Squamous Non-Small Cell Lung Cancer Therapeutics Average Price (USD/Pcs) by Players (2013-2018) 6.4 United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Share (%) of Top 3 and Top 5 Players 7 Squamous Non-Small Cell Lung Cancer Therapeutics Players/Manufacturers Profiles and Sales Data 7.1 Ascenta Therapeutics, Inc. 7.1.1 Company Basic Information, Manufacturing Base and Competitors 7.1.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 7.1.2.1 Product A 7.1.2.2 Product B 7.1.3 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 7.1.4 Main Business/Business Overview 7.2 AstraZeneca Plc 7.2.1 Company Basic Information, Manufacturing Base and Competitors 7.2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 7.2.2.1 Product A 7.2.2.2 Product B 7.2.3 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 7.2.4 Main Business/Business Overview 7.3 AVEO Pharmaceuticals, Inc. 7.3.1 Company Basic Information, Manufacturing Base and Competitors 7.3.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 7.3.2.1 Product A 7.3.2.2 Product B 7.3.3 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 7.3.4 Main Business/Business Overview 7.4 Bayer AG 7.4.1 Company Basic Information, Manufacturing Base and Competitors 7.4.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 7.4.2.1 Product A 7.4.2.2 Product B 7.4.3 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 7.4.4 Main Business/Business Overview 7.5 BIND Therapeutics, Inc. 7.5.1 Company Basic Information, Manufacturing Base and Competitors 7.5.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 7.5.2.1 Product A 7.5.2.2 Product B 7.5.3 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 7.5.4 Main Business/Business Overview 7.6 Boehringer Ingelheim GmbH 7.6.1 Company Basic Information, Manufacturing Base and Competitors 7.6.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 7.6.2.1 Product A 7.6.2.2 Product B 7.6.3 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 7.6.4 Main Business/Business Overview 7.7 Bristol-Myers Squibb Company 7.7.1 Company Basic Information, Manufacturing Base and Competitors 7.7.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 7.7.2.1 Product A 7.7.2.2 Product B 7.7.3 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 7.7.4 Main Business/Business Overview 7.8 Eli Lilly and Company 7.8.1 Company Basic Information, Manufacturing Base and Competitors 7.8.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 7.8.2.1 Product A 7.8.2.2 Product B 7.8.3 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 7.8.4 Main Business/Business Overview 7.9 F. Hoffmann-La Roche Ltd. 7.9.1 Company Basic Information, Manufacturing Base and Competitors 7.9.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 7.9.2.1 Product A 7.9.2.2 Product B 7.9.3 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 7.9.4 Main Business/Business Overview 7.10 Five Prime Therapeutics, Inc. 7.10.1 Company Basic Information, Manufacturing Base and Competitors 7.10.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 7.10.2.1 Product A 7.10.2.2 Product B 7.10.3 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 7.10.4 Main Business/Business Overview 7.11 Genentech, Inc. 7.12 Incyte Corporation 7.13 Johnson & Johnson 7.14 MacroGenics, Inc. 7.15 Novartis AG 7.16 Oncogenex Pharmaceuticals, Inc. 7.17 PsiOxus Therapeutics Limited 8 Squamous Non-Small Cell Lung Cancer Therapeutics Manufacturing Cost, Industrial Chain and Downstream Buyers 8.1 Squamous Non-Small Cell Lung Cancer Therapeutics Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Price Trend of Key Raw Materials 8.1.3 Key Suppliers of Raw Materials 8.1.4 Market Concentration Rate of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.3 Squamous Non-Small Cell Lung Cancer Therapeutics Industrial Chain Analysis 8.4 Downstream Buyers in United States 9 Marketing Strategy Analysis, Distributors and Market Effect Factors 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Distributors in Untied States 9.3 Market Effect Factors Analysis 9.3.1 Economic/Political Environmental Change 9.3.2 Downstream Demand Change 9.3.3 Technology Progress in Related Industry 9.3.4 Substitutes Threat 10 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast 10.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue Forecast (2018-2025) 10.1.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025) 10.1.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025) 10.2 United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast 10.2.1 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025) 10.2.2 United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025) 10.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Regions 10.3.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025) 10.3.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025) 10.3.3 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025) 10.3.4 South America Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025) 10.3.5 Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025) 10.4 Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Type 10.4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025) 10.4.2 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025) 10.5 Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Application 10.5.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) Forecast by Application (2018-2025) 10.5.2 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) Forecast by Application (2018-2025) 11 Research Findings and Conclusion

List of Tables and Figures Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources Figure Squamous Non-Small Cell Lung Cancer Therapeutics Product Picture Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) Status and Outlook (2013-2025) Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) Status and Outlook (2013-2025) Figure Product Picture of BMS-906024 Table Major Players of BMS-906024 Figure Global BMS-906024 Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Product Picture of Buparlisib Hydrochloride Table Major Players of Buparlisib Hydrochloride Figure Global Buparlisib Hydrochloride Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Product Picture of FP-1039 Table Major Players of FP-1039 Figure Global FP-1039 Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Product Picture of Ipilimumab Table Major Players of Ipilimumab Figure Global Ipilimumab Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Product Picture of JNJ-42756493 Table Major Players of JNJ-42756493 Figure Global JNJ-42756493 Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Product Picture of Lenvatinib Table Major Players of Lenvatinib Figure Global Lenvatinib Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Product Picture of Others Table Major Players of Others Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) by Type (2013-2018) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Share (%) by Type (2013-2018) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Type (2013-2018) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Type in 2017 Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) by Type (2013-2018) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share (%) by Type (2013-2018) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share (%) by Type (2013-2018) Figure 2017 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share (%) by Type Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Pcs) by Type (2013-2018) Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025) Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) by Type (2013-2018) Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Share (%) by Type (2013-2018) Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Type (2013-2018) Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Type in 2017 Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) by Type (2013-2018) Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share (%) by Type (2013-2018) Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share (%)by Type (2013-2018) Figure 2017 United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share (%) by Type Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Pcs) by Type (2013-2018) Figure Research Center Examples Figure Hospital Examples Figure Clinic Examples Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) Comparison by Application (2013-2025) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) by Application (2013-2018) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Share (%) by Application (2013-2018) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Application (2013-2018) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Application in 2017 Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) Comparison by Application (2013-2025) Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) by Application (2013-2018) Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Share (%) by Application (2013-2018) Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Application (2013-2018) Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Application in 2017 Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and CAGR Comparison by Regions (2013-2025) Figure North America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%)(2013-2025) Figure Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%)(2013-2025) Figure Europe Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%)(2013-2025) Figure South America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%)(2013-2025) Figure Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%)(2013-2025) Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%)(2013-2025) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) by Regions (2013-2018) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Regions (2013-2018) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Regions (2013-2018) Figure 2017 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Regions Figure 2017 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) in Global Market Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) by Regions (2013-2018) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share (%) by Regions (2013-2018) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share (%) by Regions (2013-2018) Figure 2017 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share (%) by Regions Figure 2017 United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share (%) in Global Market Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Table North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Table Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Table Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Table South America Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Table Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) of Key Players (2013-2018) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Share (%) by Players (2013-2018) Figure 2017 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Share (%) by Players Figure 2018 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Share (%) by Players Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) by Players (2013-2018) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share (%) by Players (2013-2018) Table 2017 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share (%) by Players Table 2018 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share (%) by Players Table Global Market Squamous Non-Small Cell Lung Cancer Therapeutics Average Price (USD/Pcs) by Players (2013-2018) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Top Players Manufacturing Base Distribution and Sales Area Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Top Players Product Category Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share (%) of Top 3 Players Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share (%) of Top 5 Players Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) by Players (2013-2018) Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Players (2013-2018) Figure 2017 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Share (%) by Players Figure 2018 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Share (%) by Players Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) by Players (2013-2018) Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share (%) by Players (2013-2018) Table 2017 United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share (%) by Players Table 2018 United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share (%) by Players Table United States Market Squamous Non-Small Cell Lung Cancer Therapeutics Average Price (USD/Pcs) by Players (2013-2018) Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Share (%) of Top 3 Players Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Share (%) of Top 5 Players Table Ascenta Therapeutics, Inc. Basic Information List Table Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018) Figure Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2013-2018) Figure Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Global Market Share (%)(2013-2018) Table AstraZeneca Plc Basic Information List Table AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018) Figure AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2013-2018) Figure AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Global Market Share (%)(2013-2018) Table AVEO Pharmaceuticals, Inc. Basic Information List Table AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018) Figure AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2013-2018) Figure AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Global Market Share (%)(2013-2018) Table Bayer AG Basic Information List Table Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018) Figure Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2013-2018) Figure Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Global Market Share (%)(2013-2018) Table BIND Therapeutics, Inc. Basic Information List Table BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018) Figure BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2013-2018) Figure BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Global Market Share (%)(2013-2018) Table Boehringer Ingelheim GmbH Basic Information List Table Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018) Figure Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2013-2018) Figure Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Global Market Share (%)(2013-2018) Table Bristol-Myers Squibb Company Basic Information List Table Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018) Figure Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2013-2018) Figure Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Global Market Share (%)(2013-2018) Table Eli Lilly and Company Basic Information List Table Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018) Figure Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2013-2018) Figure Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Global Market Share (%)(2013-2018) Table F. Hoffmann-La Roche Ltd. Basic Information List Table F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018) Figure F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2013-2018) Figure F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Global Market Share (%)(2013-2018) Table Five Prime Therapeutics, Inc. Basic Information List Table Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2013-2018) Figure Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2013-2018) Figure Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Global Market Share (%)(2013-2018) Table Genentech, Inc. Basic Information List Table Incyte Corporation Basic Information List Table Johnson & Johnson Basic Information List Table MacroGenics, Inc. Basic Information List Table Novartis AG Basic Information List Table Oncogenex Pharmaceuticals, Inc. Basic Information List Table PsiOxus Therapeutics Limited Basic Information List Table Sales Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Squamous Non-Small Cell Lung Cancer Therapeutics Figure Squamous Non-Small Cell Lung Cancer Therapeutics Industrial Chain Analysis Table Major Buyers of Squamous Non-Small Cell Lung Cancer Therapeutics Table Distributors/Traders List Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025) Figure United States Squamous Non-Small Cell Lung Cancer TherapeuticsSquamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025) Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) Forecast by Regions (2018-2025) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) Forecast by Regions (2018-2025) Figure North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025) Figure North America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2018-2025) Figure Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025) Figure Europe Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2018-2025) Figure Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025) Figure Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2018-2025) Figure South America Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025) Figure South America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2018-2025) Figure Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025) Figure Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2018-2025) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (Million USD) Forecast by Type (2018-2025) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) Forecast by Type (2018-2025) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) Forecast by Type (2018-2025) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share (%) Forecast by Type (2018-2025) Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (Million USD) Forecast by Type (2018-2025) Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) Forecast by Type (2018-2025) Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) Forecast by Type (2018-2025) Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share (%) Forecast by Type (2018-2025) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) Forecast by Application (2018-2025) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Forecast by Application (2018-2025) Table United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) Forecast by Application (2018-2025) Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Forecast by Application (2018-2025)